Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study

References

• Mammen MJ, Sethi S. COPD and the microbiome. Respirology. 2016;21(4):590–599.
   PubMed Web of Science ®Google Scholar
• Wang Z, Singh R, Miller BE, et al. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study. Thorax. 2018;73(4):331–338.
   PubMed Web of Science ®Google Scholar
• Pragman AA, Knutson KA, Gould TJ, et al. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study. Respir Res. 2019;20(1):114.
   PubMedGoogle Scholar
• Huang YJ, Sethi S, Murphy T, et al. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol. 2014;52(8):2813–2823.
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355–2365.
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465–471.
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA, Aris E, Bourne S, et al. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax. 2017;72(10):919–927.
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA, Aris E, Bourne SC, et al. Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort. ERJ Open Res. 2019;5(1):00248-2018.
   PubMedGoogle Scholar
• Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012;67(12):1075–1080.
   PubMed Web of Science ®Google Scholar
• Wang H, Gu X, Weng Y, et al. Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15:94.
   PubMed Web of Science ®Google Scholar
• Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(10):1224–1231.
   PubMed Web of Science ®Google Scholar
• Millares L, Ferrari R, Gallego M, et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 2014;33(7):1101–1111.
   PubMed Web of Science ®Google Scholar
• Jubinville E, Veillette M, Milot J, et al. Exacerbation induces a microbiota shift in sputa of COPD patients. PLOS One. 2018;13(3):e0194355.
   PubMed Web of Science ®Google Scholar
• López Caro JC, Santibáñez M, García Rivero JL, et al. Sputum microbiome dynamics in chronic obstructive pulmonary disease patients during an exacerbation event and post-stabilization. Respiration. 2019;98(5):447–454.
   PubMed Web of Science ®Google Scholar
• Haldar K, Bafadhel M, Lau K, et al. Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics. PLOS One. 2017;12(8):e0182833.
   PubMed Web of Science ®Google Scholar
• Wang Z, Bafadhel M, Haldar K, et al. Lung microbiome dynamics in COPD exacerbations. Eur Respir J. 2016;47(4):1082–1092.
   PubMed Web of Science ®Google Scholar
• Bourne S, Cohet C, Kim V, et al. Acute exacerbation and respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study. BMJ Open. 2014;4(3):e004546.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
   PubMed Web of Science ®Google Scholar
• Mayhew D, Devos N, Lambert C, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018;73(5):422–430.
   PubMed Web of Science ®Google Scholar
• Kim VL, Coombs NA, Staples KJ, et al. Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort. Eur Respir J. 2017;50(4):1700853.
   PubMed Web of Science ®Google Scholar
• Osman KL, Jefferies JMC, Woelk CH, et al. Patients with chronic obstructive pulmonary disease harbour a variation of Haemophilus species. Sci Rep. 2018;8(1):14734.
   PubMedGoogle Scholar
• Williams NP, Ostridge K, Devaster JM, et al. Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD. Respir Res. 2018;19(1):143.
   PubMed Web of Science ®Google Scholar
• van den Bergh MR, Spijkerman J, Swinnen KM, et al. Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis. 2013;56(3):e30–e39.
   PubMed Web of Science ®Google Scholar
• Sandstedt SA, Zhang L, Patel M, et al. Comparison of laboratory-based and phylogenetic methods to distinguish between Haemophilus influenzae and H. haemolyticus. J Microbiol Methods. 2008;75(2):369–371.
   PubMed Web of Science ®Google Scholar
• McCrea KW, Xie J, LaCross N, et al. Relationships of nontypeable Haemophilus influenzae strains to hemolytic and nonhemolytic Haemophilus haemolyticus strains. J Clin Microbiol. 2008;46(2):406–416.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Brauer AL, Sethi S, et al. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae. J Infect Dis. 2007;195(1):81–89.
   PubMed Web of Science ®Google Scholar
• Inouye M, Dashnow H, Raven LA, et al. SRST2: rapid genomic surveillance for public health and hospital microbiology labs. Genome Med. 2014;6(11):90.
   PubMed Web of Science ®Google Scholar
• Meats E, Feil EJ, Stringer S, et al. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol. 2003;41(4):1623–1636.
   PubMed Web of Science ®Google Scholar
• Parameswaran GI, Wrona CT, Murphy TF, et al. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease. BMC Infect Dis. 2009;9(1):178.
   PubMedGoogle Scholar
• Wang Z, Liu H, Wang F, et al. A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels. Front Microbiol. 2020;11:1758.
   PubMed Web of Science ®Google Scholar
• Ahearn CP, Gallo MC, Murphy TF. Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease. Pathog Dis. 2017;75(4):ftx042.
   Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Martinez FJ, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:481–504.
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Ochs-Balcom HM, Zhao J, et al. Lower airway bacterial colonization patterns and species-specific interactions in chronic obstructive pulmonary disease. J Clin Microbiol. 2018;56(10):e00330-18.
   PubMed Web of Science ®Google Scholar